Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: A prospective analysis of 1642 patients

Canadian Journal of Surgery

Volumn 52, Issue 4, 2009, Pages 295-301

  Bell, Timothy H ^a   Berta, Donna ^a   Ralley, Fiona ^a   MacDonald, Steven J ^a   McCalden, Richard W ^a   Bourne, Robert B ^a   Rorabeck, Cecil H ^a   Naudie, Douglas D R ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69049108789     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mylod AG Jr, France MP, Muser DE, et al. Perioperative blood loss associated with total knee arthroplasty: a comparison of procedures performed with and without cementing. J Bone Joint Surg Am 1990;72: 1010-1012
2. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996;78:1260-1270
3. Knight JL, Sherer D, Guo J. Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty 1998;13:70-76
4. Spence RK. Anemia in the patient undergoing surgery and the transfusion decision: a review. Clin Orthop Relat Res 1998;357:19-29.
5. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: Indications for autologous and allogenic transfusion should be the same: con. Transfusion 1995;35:450-452
6. Linden JV. Errors in transfusion medicine: scope of the problem. Arch Pathol Lab Med 1999;123:563-565
7. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991;31:212-217
8. Nelson CL. A guide to reduce allogeneic transfusions in elective orthopaedic surgery. Instr Course Lect 2005;54:35-41.
9. Sculco TP. Blood management in orthopedic surgery. Am J Surg 1995;170:60S-3S.
10. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double- blind, randomized comparison. Arch Intern Med 2000;160:2199-2207
11. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous throm- boembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(3 Suppl):338S-400S.
12. Freedman J, Luke K, Monga N, et al. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci 2005;33:343-349
13. Canadian Joint Replacement Registry. 2006 CJRR report: total hip and total knee replacements in Canada. Ottawa (ON): Canadian Institute for Health Research; 2006. Available: http ://secure.cihi.ca /cihiweb/dispPage.jsp?cw-page= PG-387-E&cw-topic=387&cw-rel=AR-30-E#full (accessed 2009 Apr. 16).
14. Francis CW, Pellegrini VD Jr, Totterman S, et al. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am 1997;79:1365-1372
15. Colwell CW Jr, Collis DK, Paulson R, et al. Comparison of enoxa- parin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999;81:932-940
16. Stern SH, Wixson RL, O'Connor D. Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty. J Arthroplasty 2000;15:153-158
17. Pagnano M, Cushner FD, Hansen A, et al. Blood management in two-stage revision knee arthroplasty for deep prosthetic infection. Clin Orthop Relat Res 1999;367:238-242
18. Shaieb MD, Watson BN, Atkinson RE. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty 1999;14:432-438
19. Scott BH, Seifert FC, Glass PS, et al. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg 2003;97:958-963
20. Churchill WH, McGurk S, Chapman RH, et al. The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. Transfusion 1998;38:530-539
21. Nuttall GA, Santrach PJ, Oliver WC Jr, et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996;36:144-149
22. Rama KRBS, Apsingi S, Poovali S, et al. Timing of tourniquet release in knee arthroplasty. Meta-analysis of randomized, controlled trials. J Bone Joint Surg Am 2007;89:699-705.
23. Juelsgaard P, Larsen UT, Sorensen JV, et al. Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med2001;26:105-110
24. Sharrock NE, Mineo R, Urquhart B, et al. The effect of two levels of hypotension on intraoperative blood loss during total hip arthro- plasty performed under lumbar epidural anesthesia. Anesth Analg 1993;76:580-584